2026年1月份股票组合

Market Overview - In December 2025, the A-share market showed a "high-level fluctuation and structural switching" pattern, with the Shanghai Composite Index rising by 2.06% and the Shenzhen Component Index increasing by 4.17%[7] - The average return of the stock portfolio in December was 6.20%, outperforming the CSI 300 Index, which rose by 2.28%[7] Stock Recommendations - Hengrui Medicine (600276): Closing price at 59.57 CNY, focusing on innovative drugs with a projected EPS of 1.31 CNY for 2025[10][12] - Luoyang Molybdenum (603993): Closing price at 20.00 CNY, benefiting from copper and gold business expansion, with an EPS forecast of 0.88 CNY[15][18] - Huaxin Cement (600801): Closing price at 24.54 CNY, with a focus on overseas expansion and an EPS estimate of 1.42 CNY[19][22] - Sanmei Co., Ltd. (603379): Closing price at 60.72 CNY, specializing in refrigerants, with an EPS forecast of 3.50 CNY[23][27] - CATL (300750): Closing price at 367.26 CNY, with a valuation recovery theme and an EPS estimate of 15.00 CNY[28][31] - Sungrow Power Supply (300274): Closing price at 171.04 CNY, benefiting from favorable conditions in new energy storage, with an EPS forecast of 7.12 CNY[32][35] - Sany Heavy Industry (600031): Closing price at 21.13 CNY, focusing on engineering machinery with an EPS estimate of 0.99 CNY[36][39] - Inovance Technology (300124): Closing price at 75.33 CNY, focusing on industrial control with an EPS forecast of 2.07 CNY[40][42] - North Huachuang (002371): Closing price at 459.08 CNY, specializing in semiconductor equipment with an EPS estimate of 9.95 CNY[43][45] Risks and Considerations - The report indicates a medium to high risk level for the stock portfolio, emphasizing the need for cautious investment decisions based on the accuracy and completeness of the information provided[6][3] - Potential risks include macroeconomic fluctuations, raw material price volatility, and regulatory changes affecting industry dynamics[11][18][19]